Plant extracts with anti-diabetic and other useful activities
View Patent ↗This invention relates to plant extracts containing nutritionally beneficial or medicinally active compounds. Some of these extracts, or the purified compounds contained therein, may be used for the nutritional support, prevention, treatment, or possible cure of various metabolic and other diseases and disorders in human beings and animals, including type 1 and type 2 diabetes, by regulating insulin signaling. This regulatory effect may include modulations of the levels and/or activity of the Insulin Receptor (IR), the Insulin-like Growth Factor (IGF) Receptor, and/or the Insulin Receptor Substrate (IRS) proteins in cells and tissues in the body.
1. A method of treating an IRS mediated disease or condition comprising administering an effective amount of a pharmaceutical composition or nutritional supplement to a subject in need thereof,
wherein the pharmaceutical composition or nutritional supplement comprises:
an aqueous extract of Artemisia dracunculus;
an aqueous extract of Cichoria endivia ; and
an aqueous extract of Lactuca sativa ; and
wherein the pharmaceutical composition or nutritional supplement is in tablet, capsule, or powder form.
2. The method of claim 1 wherein the IRS mediated disease or condition is diabetes, pre-diabetes, metabolic syndrome, insulin resistance, or dementia.
3. The method of claim 1 which further comprises administering an antidiabetic agent, insulin, metformin, exenatide, a sulfonylurea, vildagliptin, sitagliptin, a DPP4 inhibitor, meglitinide, exendin-4, liraglutide, a thiazolidinedione, empagliflozin, canagliflozin, dapagliflozin, or a GLP1 agonist.
4. The method of claim 1 wherein the pharmaceutical composition or nutritional supplement is administered orally twice per day, 30-60 minutes before meals.
5. A method of stimulating IRS2-dependent signal transduction in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition or nutritional supplement,
wherein the pharmaceutical composition or nutritional supplement comprises:
an aqueous extract of Artemisia dracunculus;
an aqueous extract of Cichoria endivia ; and
an aqueous extract of Lactuca sativa;
wherein the extracts of Artemisia dracunculus, Cichoria endivia , and Lactuca sativa are in a ratio of about 1:1,375:24 (w/w/w), respectively, and
wherein the pharmaceutical composition or nutritional supplement is in tablet, capsule, or powder form.
6. A method of stimulating IRS2-dependent signal transduction comprising contacting a cell with a botanical extract,
wherein the botanical extract provides greater than 3.6×10 4 Insulin Equivalent units in 1 milliliter comprising aqueous extracts from Artemisia dracunculus, Cichoria endivia , and Lactuca sativa.
7. A method of stimulating IRS2-dependent signal transduction comprising contacting a cell with a pharmaceutical composition or nutritional supplement,
wherein the pharmaceutical composition or nutritional supplement comprises:
an aqueous extract of Artemisia dracunculus;
an aqueous extract of Cichoria endivia ; and
an aqueous extract of Lactuca sativa ; and
wherein the pharmaceutical composition or nutritional supplement is in tablet, capsule, or powder form.